Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Currency in USD	2026
Operating Income	80.30 Million
Income Before Tax	74.40 Million
Income Tax Expense	20.70 Million
Net Income	53.70 Million
Eps	0.33
Epsdiluted	0.33
Weighted Average Shs Out	161.90 Million
Weighted Average Shs Out Dil	164.10 Million
Research And Development Expenses	30.40 Million
Selling General And Administrative Expenses	296.30 Million
Depreciation And Amortization	27.80 Million
Interest Expense	8.70 Million
Interest Income	N/A
Net Interest Income	-8.7 Million
Premiums Earned	N/A
Policyholder Benefits	N/A
Gross Profit	407.00 Million
Ebitda	108.10 Million
Source	edgar
Ebit	83.10 Million

Envista Holdings Corporation Annual Reports (10-K)